The Atlanta-based structural heart technology company, Nyra Medical, is pioneering a new approach to treating leaky mitral valves in the heart. Their innovative catheter-plug technology enhances the contour of the native leaflet with an implant, providing a first-in-class solution to a common heart condition. By developing a minimally invasive procedure that can be performed in a cath lab, Nyra Medical is revolutionizing the way leaky mitral valves are treated, offering patients a safer and more effective alternative to traditional surgery. With a mission to improve patient outcomes and reduce healthcare costs, Nyra Medical is poised to make a significant impact in the field of structural heart disease.